1. Home
  2. GBIO vs LEE Comparison

GBIO vs LEE Comparison

Compare GBIO & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • LEE
  • Stock Information
  • Founded
  • GBIO 2016
  • LEE 1890
  • Country
  • GBIO United States
  • LEE United States
  • Employees
  • GBIO N/A
  • LEE N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • LEE Newspapers/Magazines
  • Sector
  • GBIO Health Care
  • LEE Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • LEE Nasdaq
  • Market Cap
  • GBIO 41.2M
  • LEE 33.8M
  • IPO Year
  • GBIO 2020
  • LEE N/A
  • Fundamental
  • Price
  • GBIO $6.71
  • LEE $4.06
  • Analyst Decision
  • GBIO Buy
  • LEE
  • Analyst Count
  • GBIO 4
  • LEE 0
  • Target Price
  • GBIO $10.67
  • LEE N/A
  • AVG Volume (30 Days)
  • GBIO 39.3K
  • LEE 30.1K
  • Earning Date
  • GBIO 11-05-2025
  • LEE 08-07-2025
  • Dividend Yield
  • GBIO N/A
  • LEE N/A
  • EPS Growth
  • GBIO N/A
  • LEE N/A
  • EPS
  • GBIO N/A
  • LEE N/A
  • Revenue
  • GBIO $21,230,000.00
  • LEE $581,809,000.00
  • Revenue This Year
  • GBIO N/A
  • LEE N/A
  • Revenue Next Year
  • GBIO N/A
  • LEE N/A
  • P/E Ratio
  • GBIO N/A
  • LEE N/A
  • Revenue Growth
  • GBIO 61.15
  • LEE N/A
  • 52 Week Low
  • GBIO $3.00
  • LEE $3.79
  • 52 Week High
  • GBIO $25.70
  • LEE $19.63
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 65.83
  • LEE 32.48
  • Support Level
  • GBIO $6.08
  • LEE $3.83
  • Resistance Level
  • GBIO $6.48
  • LEE $4.89
  • Average True Range (ATR)
  • GBIO 0.33
  • LEE 0.42
  • MACD
  • GBIO -0.01
  • LEE -0.17
  • Stochastic Oscillator
  • GBIO 83.58
  • LEE 10.53

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

Share on Social Networks: